Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Part D low-income shifts

Executive Summary

UnitedHealth is among a minority of the leading Medicare Part D sponsors that added auto-assigned low-income members for 2009 with a gain of 120,000. Universal American was another, with 145,000 net new Medicaid/Medicare dual-eligibles. Among those who lost low-income members, WellCare reported 252,000 fewer dual-eligible members in 2009, and Humana lost 300,000 dual-eligibles. Overall, CMS had to re-assign nearly 1.2 million low-income beneficiaries to a new Part D sponsoring organization in 2009, which is roughly on par with 2008. But the availability of plans qualified for low-income subsidy beneficiaries is shrinking; in states such as Florida, Arizona and Nevada and in the New England region, there are now only five or fewer plans available, according to an analysis by Avalere Health

You may also be interested in...



Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines

Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS050694

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel